I) Respiratorisches-Syncytial-Virus (RSV) Adjuvans-Impfstoff, rekombiniert, monovalent (w)
Respiratorisches Syncytial-Virus-Glycoprotein F3 (hergestellt mittels rekombinanter DNA-Technologie in Ovarienzellen des chinesischen Hamsters (CHO-Zellen)) (120 mcg) (w)
Trehalose-2-Wasser (H)
Polysorbat 80 (H)
Kaliumdihydrogenphosphat (H)
Kaliummonohydrogenphosphat (H)
II) 3-O-Desacyl-4'-monophosphoryl-Lipid A (MPL) (H)
Seifenrinde-Extrakt (QS-21) (H)
Dioleoyl-Phosphatidylcholin (DOPC) (H)
Cholesterol (H)
Dinatriumhydrogenphosphat (H)
Kaliumdihydrogenphosphat (H)
Natriumchlorid (H)
I) et II) corresp.: Respiratorisches Syncytial-Virus-Glycoprotein F3 (120 mcg)
Trehalose-2-Wasser (H)
Polysorbat 80 (H)
Kaliumdihydrogenphosphat (H)
Kaliummonohydrogenphosphat (H)
3-O-Desacyl-4'-monophosphoryl-Lipid A (MPL) (H)
Seifenrinde-Extrakt (QS-21) (H)
Dioleoyl-Phosphatidylcholin (DOPC) (H)
Cholesterol (H)
Natriumchlorid (H)
Dinatriumhydrogenphosphat (H)
corresp.: Natrium (1.78 mg) (H)
et Kalium (0.35 mg) (H)
Aqua ad susp. iniect. pro 0.5 ml